Literature DB >> 27038603

Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Jayden A Clark1, Katherine A Southam1, Catherine A Blizzard1, Anna E King2, Tracey C Dickson3.   

Abstract

Degeneration of the distal axon and neuromuscular junction (NMJ) is considered a key and early feature of the pathology that accompanies motor neuron loss in people with amyotrophic lateral sclerosis (ALS). The mutant SOD1(G93A) mouse replicates many features of the disease, however the sequence of events resulting in degeneration of the neuromuscular circuitry remains unknown. Furthermore, despite widespread degenerative neuronal pathology throughout the spinal cord in this model, hindlimb motor function is lost before forelimb function. We investigated axons and NMJs in the hindlimb (gastrocnemius) and forelimb (extensor) muscles in the high copy number mutant SOD1(G93A)xYFP (yellow fluorescent protein) mouse. We found that distal axonal and NMJ alterations were present prior to previously reported functional symptom onset in this strain. Indeed, increased branch complexity as well as colocalisation between pre- and post-synaptic markers indicated widespread early axonal and NMJ alterations in the hindlimb. Immunohistochemical analysis demonstrated that the colocalisation of the scaffolding proteins nestin, LRP-4, dystrophin and rapsyn were diminished before post-synaptic receptors in the gastrocnemius, and the degree of loss differed between proteins. Analysis of the forelimb muscle revealed axonal and NMJ degeneration at a late, post symptomatic stage, as well as novel differences in NMJ morphology, with reduced complexity. Furthermore, post-synaptic scaffolding proteins were preserved in the forelimb compared with the hindlimb. Analysis of protein levels indicated an increase in LRP-4, dystrophin and rapsyn in post symptomatic skeletal muscle that may suggest ongoing attempts at repair. This study indicates that axonal and NMJ degeneration in the SOD1 model of ALS is a complex and evolving sequence of events. We provide evidence that YFP can detect morphological and plastic alterations in the SOD1(G93A) mouse, and that the pre- and post-synaptic integrity of the NMJ plays an important role in the pathogenic mechanisms of ALS.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Distal 'dying back' degeneration; Forelimb pathology; Neuromuscular junction; SOD1(G93A) mouse

Mesh:

Substances:

Year:  2016        PMID: 27038603     DOI: 10.1016/j.jchemneu.2016.03.003

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  39 in total

1.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

2.  The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.

Authors:  Poulomee Bose; Elsa Tremblay; Claudia Maois; Vijay Narasimhan; Gary A B Armstrong; Meijiang Liao; J Alex Parker; Richard Robitaille; Xiao Yan Wen; Christopher Barden; Pierre Drapeau
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 3.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

4.  Motoneuron Diseases.

Authors:  Francesco Lotti; Serge Przedborski
Journal:  Adv Neurobiol       Date:  2022

5.  Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice.

Authors:  Maria Chiara Trolese; Carlotta Scarpa; Valentina Melfi; Paola Fabbrizio; Francesca Sironi; Martina Rossi; Caterina Bendotti; Giovanni Nardo
Journal:  Mol Ther       Date:  2022-04-27       Impact factor: 12.910

6.  Altered perivascular fibroblast activity precedes ALS disease onset.

Authors:  Anna Månberg; Nathan Skene; Folkert Sanders; Marta Trusohamn; Julia Remnestål; Anna Szczepińska; Inci Sevval Aksoylu; Peter Lönnerberg; Lwaki Ebarasi; Stefan Wouters; Manuela Lehmann; Jennie Olofsson; Inti von Gohren Antequera; Aylin Domaniku; Maxim De Schaepdryver; Joke De Vocht; Koen Poesen; Mathias Uhlén; Jasper Anink; Caroline Mijnsbergen; Hermieneke Vergunst-Bosch; Annemarie Hübers; Ulf Kläppe; Elena Rodriguez-Vieitez; Jonathan D Gilthorpe; Eva Hedlund; Robert A Harris; Eleonora Aronica; Philip Van Damme; Albert Ludolph; Jan Veldink; Caroline Ingre; Peter Nilsson; Sebastian A Lewandowski
Journal:  Nat Med       Date:  2021-04-15       Impact factor: 87.241

7.  Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease.

Authors:  Qiao Ding; Kaamini Kesavan; Robert D Henderson; Pamela A McCombe; Rosalind L Jeffree; William D Phillips; Ernst J Wolvetang; Shyuan T Ngo; Peter G Noakes; Kah Meng Lee; Elyse Wimberger; Thomas Robertson; Melinder Gill; Dominique Power; Jeryn Chang; Atefeh T Fard; Jessica C Mar; Susan Heggie; Michael J Colditz; Massimo A Hilliard; Dominic C H Ng; Frederik J Steyn
Journal:  Acta Neuropathol Commun       Date:  2022-04-25       Impact factor: 7.578

8.  Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports.

Authors:  Hisashi Takahashi; Yu-Ichi Noto; Naoki Makita; Yukie Kushimura-Okada; Ryotaro Ishii; Akihiro Tanaka; Tomoyuki Ohara; Shunya Nakane; Osamu Higuchi; Masanori Nakagawa; Toshiki Mizuno
Journal:  BMC Neurol       Date:  2016-11-18       Impact factor: 2.474

9.  Diaphragm neuromuscular transmission failure in a mouse model of an early-onset neuromotor disorder.

Authors:  Matthew J Fogarty; Joline E Brandenburg; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2020-12-31

Review 10.  Modelling and Refining Neuronal Circuits with Guidance Cues: Involvement of Semaphorins.

Authors:  Greta Limoni
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.